# Omega-3 Fatty Acids in Bipolar Disorder

> **NCT00010868** · PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)**

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Omega-3 Fatty Acids

## Key facts

- **NCT ID:** NCT00010868
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2004-07
- **Target enrollment:** — (—)
- **Last updated:** 2006-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010868, "Omega-3 Fatty Acids in Bipolar Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00010868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*